Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2007-4-10
pubmed:databankReference
http://linkedlifedata.com/resource/pubmed/xref/GENBANK/AM039444, http://linkedlifedata.com/resource/pubmed/xref/GENBANK/AM039445, http://linkedlifedata.com/resource/pubmed/xref/GENBANK/AM039446, http://linkedlifedata.com/resource/pubmed/xref/GENBANK/AM039447, http://linkedlifedata.com/resource/pubmed/xref/GENBANK/AM039448, http://linkedlifedata.com/resource/pubmed/xref/GENBANK/AM039449, http://linkedlifedata.com/resource/pubmed/xref/GENBANK/AM109953, http://linkedlifedata.com/resource/pubmed/xref/GENBANK/AM109954, http://linkedlifedata.com/resource/pubmed/xref/GENBANK/AM109955, http://linkedlifedata.com/resource/pubmed/xref/GENBANK/AM109956, http://linkedlifedata.com/resource/pubmed/xref/GENBANK/AM109957, http://linkedlifedata.com/resource/pubmed/xref/PDB/2IXA, http://linkedlifedata.com/resource/pubmed/xref/PDB/2IXB
pubmed:abstractText
Enzymatic removal of blood group ABO antigens to develop universal red blood cells (RBCs) was a pioneering vision originally proposed more than 25 years ago. Although the feasibility of this approach was demonstrated in clinical trials for group B RBCs, a major obstacle in translating this technology to clinical practice has been the lack of efficient glycosidase enzymes. Here we report two bacterial glycosidase gene families that provide enzymes capable of efficient removal of A and B antigens at neutral pH with low consumption of recombinant enzymes. The crystal structure of a member of the alpha-N-acetylgalactosaminidase family reveals an unusual catalytic mechanism involving NAD+. The enzymatic conversion processes we describe hold promise for achieving the goal of producing universal RBCs, which would improve the blood supply while enhancing the safety of clinical transfusions.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1087-0156
pubmed:author
pubmed:issnType
Print
pubmed:volume
25
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
454-64
pubmed:meshHeading
pubmed-meshheading:17401360-ABO Blood-Group System, pubmed-meshheading:17401360-Bacteria, pubmed-meshheading:17401360-Binding Sites, pubmed-meshheading:17401360-Blood Grouping and Crossmatching, pubmed-meshheading:17401360-Catalysis, pubmed-meshheading:17401360-Chromatography, Thin Layer, pubmed-meshheading:17401360-Erythrocytes, pubmed-meshheading:17401360-Flow Cytometry, pubmed-meshheading:17401360-Glycoside Hydrolases, pubmed-meshheading:17401360-Humans, pubmed-meshheading:17401360-Hydrogen-Ion Concentration, pubmed-meshheading:17401360-Kinetics, pubmed-meshheading:17401360-Molecular Sequence Data, pubmed-meshheading:17401360-Prokaryotic Cells, pubmed-meshheading:17401360-Protein Structure, Secondary, pubmed-meshheading:17401360-Substrate Specificity, pubmed-meshheading:17401360-Titrimetry, pubmed-meshheading:17401360-alpha-N-Acetylgalactosaminidase
pubmed:year
2007
pubmed:articleTitle
Bacterial glycosidases for the production of universal red blood cells.
pubmed:affiliation
ZymeQuest Inc., 100 Cummings Center, Suite 436H, Beverly, Massachusetts 01915, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't